300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Mobile
Wellness
Education
Automotive
Hospitality
Sports
Legal
Biotechnology
eSports
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Medical
Infrastructure
Recruiting
Cannabis
Web3
Mobile Apps
LGBT
Life Science
Celebrity
Climate
Wine and Spirits
Music
Art
Real Estate
Food and Beverage
Sporting Goods
Publishing
Manufacturing
Digital Media
Financial Services
FinTech
Social Media
Finance
Franchise
Mobile Advertising
Android
Sustainability
Hardware
Non Profit
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Internet
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Gibraltar
Africa
Oceania
Liberia
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Panama
Nicaragua
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Kazakhstan
Guatemala
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
United Kingdom
Ghana
Iraq
Malaysia
Mali
Latvia
Sierra Leone
Portugal
Rwanda
El Salvador
Philippines
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Qatar
Belgium
Jordan
Barbados
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Austria
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Ethiopia
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
SYGMA.Novosibirsk, VC Fund

SYGMA.Novosibirsk

VC Fund

SYGMA.Novosibirsk is a VC fund focused on Biotechnology and Health Diagnostics. Material-based startups building and selling. A subsidiary of JSC RUSNANO.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries SYGMA.Novosibirsk invests in

BiotechnologyHealth Diagnostics

Stages SYGMA.Novosibirsk invests in

Seed

Countries SYGMA.Novosibirsk invests in

Russian Federation

Investment Focus

Industry

  • Biotechnology 1 (100%)
  • Health Diagnostics 1 (100%)

Investments

CompanyDescriptionRoundLinks
EpiGene EpiGene
EpiGene is a medical company that provides early cancer diagnostics to allows applying an effective treatment and saving a life of patient. It uses method of early cancer diagnostics based on DNA molecule analysis. Seed / Dec 07, 2016

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Mobile
Wellness
Education
Automotive
Hospitality
Sports
Legal
Biotechnology
eSports
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Medical
Infrastructure
Recruiting
Cannabis
Web3
Mobile Apps
LGBT
Life Science
Celebrity
Climate
Wine and Spirits
Music
Art
Real Estate
Food and Beverage
Sporting Goods
Publishing
Manufacturing
Digital Media
Financial Services
FinTech
Social Media
Finance
Franchise
Mobile Advertising
Android
Sustainability
Hardware
Non Profit
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Internet
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Gibraltar
Africa
Oceania
Liberia
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Panama
Nicaragua
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Kazakhstan
Guatemala
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Canada
Georgia
Denmark
United Kingdom
Ghana
Iraq
Malaysia
Mali
Latvia
Sierra Leone
Portugal
Rwanda
El Salvador
Philippines
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Qatar
Belgium
Jordan
Barbados
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Austria
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Ethiopia
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does SYGMA.Novosibirsk invest in?

SYGMA.Novosibirsk invests primarily in Biotechnology and Health Diagnostics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Russian Federation. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did SYGMA.Novosibirsk last invest?

The most recent investment recorded for SYGMA.Novosibirsk closed in Dec 2016. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
SYGMA.Novosibirsk SYGMA.Novosibirsk Find emails